Source: International Congress 2016 – Prognostic variables in lung cancer I
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Roberto Chalela (Barcelona, Spain), Roberto Chalela, Beatriz Bellosillo, Víctor Curull, Lara Pijuan, Joaquín Gea. Prevalence of molecular changes in resected pulmonary adenocarcinomas. Eur Respir J 2016; 48: Suppl. 60, 2853

Member's Comments

No comment yet.

Related content which might interest you: Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Clinicopathological prognostic factors in operated for pulmonary carcinoid tumor patients Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP) Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy Year: 2013 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 Clinical characteristics of 32 patients with BRAF V600E-mutated lung adenocarcinoma Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Frequency and type of EGFR mutations in patients with adenocarcinoma of the lung Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement: Analysis of two cases and literature review Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Molecular profiling of lung squamous carcinogenesis Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor? Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Prevalence of preinvasive bronchial lesions in patients with lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Correlation between clinical and pathological factors in resected lung carcinoid tumours Source: International Congress 2016 – Special issues in thoracic surgery Year: 2016 Automated target-FISH lung cancer detection (LCD) test of induced sputum Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Methylation of p16 in EBUS-TBNA samples as a predictor of advanced disease in lung cancer Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013